Top compounds associated with response to PAWR


Feature Type Standardized
Nominal ANOVA
mRNA fingolimod CTRPv2 pan-cancer AAC -0.082 0.04
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.04
mRNA pac-1 CTRPv2 pan-cancer AAC -0.082 0.05
mRNA BRD6340 CTRPv2 pan-cancer AAC -0.08 0.05
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.07 0.05
mRNA SNS-032 CTRPv2 pan-cancer AAC -0.081 0.05
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.05
mRNA Pazopanib GDSC1000 pan-cancer AAC -0.08 0.05
mRNA MLN2480 CTRPv2 pan-cancer AAC -0.12 0.05
mRNA Oxaliplatin CTRPv2 pan-cancer AAC -0.074 0.05
Download CSV